1. Proteau, Sarah, Krossa, Imène, Husser, Chrystel, Bertolotto, Corine, Strub, Thomas. 2023. LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. In EMBO molecular medicine, 15, e17719. doi:10.15252/emmm.202317719. https://pubmed.ncbi.nlm.nih.gov/37966164/
2. Lu, Zhen, Mao, Weiqun, Yang, Hailing, Vankayalapati, Hariprasad, Bast, Robert C. . SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. In The Journal of clinical investigation, 132, . doi:10.1172/JCI146471. https://pubmed.ncbi.nlm.nih.gov/35642638/
3. Imielinski, Marcin, Berger, Alice H, Hammerman, Peter S, Getz, Gad, Meyerson, Matthew. . Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. In Cell, 150, 1107-20. doi:10.1016/j.cell.2012.08.029. https://pubmed.ncbi.nlm.nih.gov/22980975/
4. Gao, Tian, Zhang, Xiaohong, Zhao, Jing, Li, Jibin, Liu, Shujuan. 2019. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. In Cancer letters, 469, 89-101. doi:10.1016/j.canlet.2019.10.029. https://pubmed.ncbi.nlm.nih.gov/31639424/
5. Yoon, Sung-Hee, Meyer, Mark B, Arevalo, Carlos, Mannstadt, Michael, Wein, Marc N. 2023. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. In The Journal of clinical investigation, 133, . doi:10.1172/JCI163627. https://pubmed.ncbi.nlm.nih.gov/36862513/
6. Dai, Xiao-Man, Zhang, Yan-Hui, Lin, Xiao-Han, Lin, Xin-Jian, Lin, Xu. 2020. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases. In Molecular oncology, 15, 228-245. doi:10.1002/1878-0261.12838. https://pubmed.ncbi.nlm.nih.gov/33128264/
7. Zhang, Zhen-Ning, Gong, Lulu, Lv, Sihan, Zhang, Chao, Luan, Bing. 2016. SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300. In Scientific reports, 6, 23317. doi:10.1038/srep23317. https://pubmed.ncbi.nlm.nih.gov/26983400/
8. Xu, Yan, Xu, Li, Kong, Yi, Liang, Shuzhi, Chen, Bolin. 2023. IGF2BP1 enhances the stability of SIK2 mRNA through m6A modification to promote non-small cell lung cancer progression. In Biochemical and biophysical research communications, 684, 149113. doi:10.1016/j.bbrc.2023.10.045. https://pubmed.ncbi.nlm.nih.gov/37866243/
智鼠故事 
